<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE IDEXX
LABORATORIES, INC. UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR
THE SECOND QUARTER ENDING JUNE 30, 1996 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>
<CIK> 0000874716
<NAME> IDEXX LABORATORIES, INC.
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS
       
                             
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               JUN-30-1996
<EXCHANGE-RATE>                                      1
<CASH>                                     139,408,462
<SECURITIES>                                48,022,684
<RECEIVABLES>                               62,719,881
<ALLOWANCES>                                 3,179,000
<INVENTORY>                                 40,195,223
<CURRENT-ASSETS>                           295,815,460
<PP&E>                                      47,772,659
<DEPRECIATION>                              17,797,580
<TOTAL-ASSETS>                             348,829,150
<CURRENT-LIABILITIES>                       50,010,682
<BONDS>                                              0
<COMMON>                                     3,695,342
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                 295,123,126
<TOTAL-LIABILITY-AND-EQUITY>               348,829,150
<SALES>                                    123,275,066
<TOTAL-REVENUES>                           123,275,066
<CGS>                                       53,086,914
<TOTAL-COSTS>                               53,086,914
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             126,700
<INCOME-PRETAX>                             25,174,800
<INCOME-TAX>                                10,321,668
<INCOME-CONTINUING>                         14,853,132
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                14,853,132
<EPS-PRIMARY>                                      .38
<EPS-DILUTED>                                      .38